TITLE

Evolution of Untreated Hereditary Hemochromatosis in the Busselton Population: A 17-Year Study

AUTHOR(S)
Olynyk, Jown K.; Hagan, Simone E.; Cullen, Digby J.; Beilby, John; Whittall, Davina E.
PUB. DATE
March 2004
SOURCE
Mayo Clinic Proceedings;Mar2004, Vol. 79 Issue 3, p309
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
•Objective: To describe the evolution of biochemical and clinical features during a 17-year period in untreated subjects homozygous for the C282Y mutation in the hemochromatosis gene. • Subjects and Methods: In 1998, 12 subjects from Busselton, Australia, were newly diagnosed as being homozygous for the C282Y mutation. We determined transferrin saturation and ferritin values and retrieved clinical information from the 1981, 1994, and 1998 population surveys for 10 of these subjects. • Results: The median age of the 10 subjects in 1981 was 30 years. Between 1981 and 1998, the median transferrin saturation value increased from 42% to 76%. Six subjects with elevated transferrin saturation in 1998 had values less than 45% in 1981. Between 1981 and 1998, the median serum ferritin levels increased from 271 μg/L to 593 μg/L. Serum ferritin levels increased in 4 subjects, remained relatively constant in 4, and decreased in 2. Of 5 subjects with serum ferritin levels lower than 200 μg/L in 1981, 4 had no increase in these levels between 1981 and 1998. Of 4 subjects with persistently elevated serum ferritin levels greater than 500 μ/L, 3 developed stage III or IV fibrosis, based on the METAVIR scoring system. • Conclusions: Untreated C282Y homozygous subjects had progressively increasing transferrin saturation values but marked variation in serum ferritin levels during a 17- year period before diagnosis. A screening threshold for serum transferrin saturation values greater than 45% at an early stage in adult life could fail to detect 60% of C282Y homozygotes who subsequently develop biochemical features of hemochromatosis.
ACCESSION #
12389653

 

Related Articles

  • Hemochromatosis Gene Sequence Deviations in German Patients with Porphyria Cutanea Tarda. Frank, J.; Poblete-Gutiérrez, P.; Weiskirchen, R.; Gressner, O.; Merk, H. F.; Lammert, F. // Physiological Research;2006 Supplement, Vol. 55, pS75 

    Patients with porphyria cutanea tarda (PCT) reveal a susceptibility to reversible inactivation of hepatic uroporphyrinogen decarboxylase, which might be triggered by alcohol, hepatitis C virus infection, and iron overload. Inherited factors that may predispose to clinically overt PCT also...

  • Mutation analysis of the HFE gene associated with hereditary hemochromatosis in a Venezuelan sample. Vizzi, Esmeralda; Loureiro, Carmen Luisa; Gerder, Marlene; Garcia-Casal, María de las Nieves; Rodríguez-Larralde, Alvaro; Gerace, Letizia; Ludert, Juan Ernesto; Liprandi, Ferdinando; Pujol, Flor Helene // Annals of Hematology;Dec2005, Vol. 84 Issue 12, p802 

    The frequency of the C282Y, H63D and S65C alleles of the HFE gene was determined in a sample of the Venezuelan population. Two new sets of primers were tested for amplifying the regions mapping these mutations, and genotyping was performed by restriction fragment length polymorphism (RFLP). DNA...

  • Homozygous G320V Mutation in the HJV Gene Causing Juvenile Hereditary Haemochromatosis Type A. A Case Report. Militaru, Mariela S.; Popp, Radu A.; Trifa, Adrian P. // Journal of Gastrointestinal & Liver Diseases;Jun2010, Vol. 19 Issue 2, p191 

    While classical hereditary haemochromatosis, usually associated with mutations in the HFE gene, has an adult age onset and a long, progressive evolution, juvenile haemochromatosis, most often associated with mutations in the HJV gene, is a more severe, rapidly progressive condition and has an...

  • Should we screen for hereditary hemochromatosis in healthy Lebanese: a pilot study. Mahfouz, Rami; Sarieddine, Doja; Charafeddine, Khalil; Abdul Khalik, Rabab; Cortas, Najwa; Daher, Rose // Molecular Biology Reports;Jan2012, Vol. 39 Issue 1, p753 

    Hereditary hemochromatosis (HHC) is a genetic disorder of iron metabolism characterized by abnormal accumulation of iron that may lead to organ damage and death. Diagnosis is usually based on various genetic and phenotypic criteria. The study goals were to perform mutation analysis for 18...

  • ATYPICAL HAEMOCHROMATOSIS ASSOCIATED WITH NOVEL MUTATIONS IN THE FERROPORTIN GENE. Griffiths, W. J. H.; Mocfarlane, I.; Halsall, D.; Davies, S.; Cox, T. M. // Gut;Apr2004 Supplement 3, Vol. 53, pA11 

    The genetic basis of non-HFE haemochromatosis is being unravelled. Mutations in the ferroportin gene, which encodes a cellular iron-export protein, account for the dominantly inherited HFE4 variant characterised by high ferritin, low transferrin saturation, early Kupffer cell iron loading, and...

  • Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population. Adams, Paul C.; Reboussin, David M.; Barton, James C.; McLaren, Christine E.; Eckfeldt, John H.; McLaren, Gordon D.; Dawkins, Fitzroy W.; Acton, Ronald T.; Harris, Emily L.; Gordeuk, Victor R.; Leiendecker-Foster, Catherine; Speechley, Mark; Snively, Beverly M.; Holup, Joan L.; Thomson, Elizabeth; Sholinsky, Phyliss // New England Journal of Medicine;4/28/2005, Vol. 352 Issue 17, p1769 

    Background: Iron overload and hemochromatosis are common, treatable conditions. HFE genotypes, levels of serum ferritin, transferrin saturation values, and self-reported medical history were studied in a multiethnic primary care population. Methods: Participants were recruited from primary care...

  • Longevity and C282Y mutation for haemochromatosis. Li, Andy C. Y.; Powell, Jonathan // BMJ: British Medical Journal (International Edition);10/25/2003, Vol. 327 Issue 7421, p990 

    Presents a letter to the editor regarding the survival of people who were homozygous for the C282Y mutation among a cohort of French centenarians without treatment for hemochromatosis.

  • Longevity and C282Y mutation for haemochromatosis. Willis, Gavin; Jennings, Barbara A.; Wimperis, Jennie Z. // BMJ: British Medical Journal (International Edition);10/25/2003, Vol. 327 Issue 7421, p991 

    Presents a response to a letter to the editor regarding the survival of people who were homozygous for the C282Y mutation among a cohort of French centenarians without treatment for hemochromatosis.

  • Longevity and C282Y mutation for haemochromatosis. Coppin, Hélène; Roth, Marie-Paule; Blanché, Hélène // BMJ: British Medical Journal (International Edition);10/25/2003, Vol. 327 Issue 7421, p990 

    Presents a letter to the editor regarding the survival of people who were homozygous for the C282Y mutation among a cohort of French centenarians without treatment for hemochromatosis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics